CNS Pharmaceuticals, Inc. — 10-K/A Filings
5 10-K/A filings on record
This page lists all 10-K/A filings submitted to the SEC by CNS Pharmaceuticals, Inc. (CNSP), sorted by most recent first. Each row links to the full filing on EdgarLookup. CNS Pharmaceuticals, Inc. has filed 5 10-K/A documents with the SEC since 2018. To view all SEC filings by CNS Pharmaceuticals, Inc., see the full filings list.
All
1-A
1-A-W
1-A/A
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
C
C-AR
C-TR
C-U
CERT
CORRESP
DEF 14A
DEFA14A
DEFR14A
DOS
DRS
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001683168-25-002998 | Apr 30, 2025 | Dec 31, 2024 |
| 10-K/A | 10-K/A | 0001683168-23-002817 | May 1, 2023 | Dec 31, 2022 |
| 10-K/A | FORM 10-K AMENDMENT 1 | 0001683168-22-003055 | Apr 29, 2022 | Dec 31, 2021 |
| 10-K/A | AMENDMENT #2 TO THE ANNUAL REPORT | 0001683168-21-001671 | Apr 30, 2021 | Dec 31, 2020 |
| 10-K/A | AMENDED ANNUAL REPORT | 0001683168-21-000560 | Feb 16, 2021 | Dec 31, 2020 |